ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 90 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2020. The put-call ratio across all filers is 0.71 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96,263 | -59.9% | 21,297 | +0.0% | 0.00% | – |
| Q4 2022 | $239,973 | -4.0% | 21,293 | -18.8% | 0.00% | – |
| Q3 2022 | $250,000 | +106.6% | 26,233 | +73.1% | 0.00% | – |
| Q2 2022 | $121,000 | -49.6% | 15,157 | +6.6% | 0.00% | – |
| Q1 2022 | $240,000 | -19.2% | 14,217 | +2.8% | 0.00% | – |
| Q4 2021 | $297,000 | -8.3% | 13,834 | +216.0% | 0.00% | – |
| Q3 2021 | $324,000 | +44.6% | 4,378 | +6.6% | 0.00% | – |
| Q2 2021 | $224,000 | -50.4% | 4,107 | -33.0% | 0.00% | – |
| Q1 2021 | $452,000 | -61.3% | 6,133 | -54.7% | 0.00% | -100.0% |
| Q4 2020 | $1,168,000 | – | 13,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |